HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giorgio Battaglia Selected Research

Periventricular Nodular Heterotopia

9/2006NMDA receptor composition differs among anatomically diverse malformations of cortical development.
4/2005Electroencephalographic recordings of focal seizures in patients affected by periventricular nodular heterotopia: role of the heterotopic nodules in the genesis of epileptic discharges.
9/2003The genesis of epileptogenic cerebral heterotopia: clues from experimental models.
7/2003Neurogenesis in cerebral heterotopia induced in rats by prenatal methylazoxymethanol treatment.
6/2003The NMDA receptor complex is altered in an animal model of human cerebral heterotopia.
1/2002AlphaCaMKII and NMDA-receptor subunit expression in epileptogenic cortex from human periventricular nodular heterotopia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giorgio Battaglia Research Topics

Disease

14Neoplasms (Cancer)
01/2019 - 03/2007
9Adenocarcinoma
06/2017 - 03/2004
8Carcinogenesis
12/2017 - 07/2010
7Deglutition Disorders (Dysphagia)
04/2016 - 03/2007
6Esophageal Neoplasms (Esophageal Cancer)
01/2020 - 11/2008
6Seizures (Absence Seizure)
01/2016 - 09/2003
6Periventricular Nodular Heterotopia
09/2006 - 01/2002
5Metaplasia
01/2014 - 12/2005
5Epilepsy (Aura)
09/2013 - 01/2002
4Barrett Esophagus (Barrett's Esophagus)
12/2017 - 01/2011
3Malformations of Cortical Development
09/2013 - 09/2006
3Esophageal Achalasia (Megaesophagus)
12/2008 - 02/2002
2Fibrosis (Cirrhosis)
07/2019 - 12/2010
2Pathologic Constriction (Stenosis)
01/2016 - 03/2007
2Status Epilepticus (Complex Partial Status Epilepticus)
09/2013 - 10/2011
2Spinal Muscular Atrophy (Progressive Muscular Atrophy)
05/2012 - 03/2006
2Carcinoma (Carcinomatosis)
12/2010 - 12/2007
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2010 - 11/2008
2Partial Epilepsies (Epilepsy, Partial)
08/2003 - 07/2003
1Inflammation (Inflammations)
07/2019
1Kidney Diseases (Kidney Disease)
07/2019
1Gastroesophageal Reflux (GERD)
06/2017
1Disease Progression
06/2017
1Hyperinsulinism (Hyperinsulinemia)
06/2017
1Insulin Resistance
06/2017
1Encephalitis (Encephalitis, Rasmussen)
01/2016
1Temporal Lobe Epilepsy
01/2016
1Infections
12/2013
1Inborn Genetic Diseases (Disease, Hereditary)
12/2013
1Proteinuria
12/2013
1Amyloidosis
12/2013
1Liver Neoplasms (Liver Cancer)
11/2012
1Hypertension (High Blood Pressure)
11/2012
1Neuroblastoma
05/2012
1Esophagitis
01/2012
1Hiatal Hernia
01/2012
1Visceral Leishmaniasis (Kala Azar)
06/2011

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
12/2013 - 03/2006
5Pharmaceutical PreparationsIBA
12/2006 - 07/2003
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2011 - 01/2002
3Methylazoxymethanol AcetateIBA
10/2011 - 07/2003
2PlatinumIBA
01/2020 - 05/2016
2Cell-Free Nucleic AcidsIBA
12/2017 - 10/2016
2methylazoxymethanolIBA
09/2013 - 06/2003
2Pilocarpine (Ocusert)FDA LinkGeneric
09/2013 - 10/2011
2MicroRNAs (MicroRNA)IBA
05/2013 - 10/2011
2Biological ProductsIBA
11/2012 - 07/2010
2MetalsIBA
01/2011 - 12/2007
2PlasticsIBA
12/2007 - 03/2007
1AldosteroneIBA
07/2019
1Mineralocorticoid Receptor AntagonistsIBA
07/2019
1CollagenIBA
07/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017
1Glucagon (Glukagon)FDA Link
06/2017
1Insulin (Novolin)FDA Link
06/2017
1LeptinIBA
06/2017
1C-PeptideIBA
06/2017
1Interleukin-6 (Interleukin 6)IBA
06/2017
1AdiponectinIBA
06/2017
1DNA (Deoxyribonucleic Acid)IBA
10/2016
1InterleukinsIBA
01/2016
1Kainic Acid (Kainate)IBA
01/2016
1Serum AlbuminIBA
01/2016
1Peptides (Polypeptides)IBA
01/2015
1Omeprazole (Prilosec)FDA LinkGeneric
01/2014
1Proton Pump InhibitorsIBA
01/2014
1Amyloid (Amyloid Fibrils)IBA
12/2013
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2013
1Blood Proteins (Serum Proteins)IBA
12/2013
1AA amyloidosisIBA
12/2013
1N-Methylaspartate (NMDA)IBA
09/2013
1Glutamic Acid (Glutamate)FDA Link
09/2013
1Guanylate KinasesIBA
09/2013
1Liposomes (Liposome)IBA
11/2012
1MicellesIBA
11/2012
1human ERBB2 proteinIBA
11/2012
1Messenger RNA (mRNA)IBA
11/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2012
1XenonIBA
11/2012
1Protein Isoforms (Isoforms)IBA
05/2012
1BariumIBA
01/2012
1Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
06/2011
1miltefosine (Impavido)IBA
06/2011
1Amphotericin B (Amphotericin)FDA LinkGeneric
06/2011
1Pentamidine (NebuPent)FDA LinkGeneric
06/2011

Therapy/Procedure

5Therapeutics
01/2020 - 04/2003
5Stents
04/2016 - 03/2007
4Esophagectomy
10/2011 - 03/2004
3Lasers (Laser)
01/2015 - 01/2011
3Fundoplication
01/2012 - 03/2004
3Myotomy
12/2008 - 02/2002
2Self Expandable Metallic Stents
04/2016 - 12/2007
2Palliative Care (Palliative Therapy)
01/2016 - 01/2011
2Electrodes (Electrode)
04/2005 - 01/2002
2Heller Myotomy
03/2004 - 02/2002
1Drug Therapy (Chemotherapy)
05/2016
1Neoadjuvant Therapy
05/2016
1Brachytherapy
01/2011